Calibration and standardization of Peptide Synthesizer

The Food and Drug Administration is forecasting a requirement for the calibration and standardization of peptide synthesizer equipment, with the North American Industry Classification System code 334516 indicating focus on laboratory analytical instrument manufacturing services. This contract opportunity is intended to ensure precision and reliability in peptide synthesis processes critical to regulatory and research functions, though specific technical specifications, duration, or performance timelines are not yet defined. The work is expected to maintain compliance with federal standards for analytical instrument performance, with potential performance locations unspecified at this stage. Point of contact for inquiries is the CBER Acquisition Liaison at cberacquisitions@fda.hhs.gov, while the Contracting Officer position remains vacant and will be assigned prior to formal solicitation. The forecast was posted on May 25, 2026, and serves as a pre-solicitation notice to inform industry partners of an upcoming procurement; no formal solicitation number has been issued. Interested vendors should monitor the official OSDBU opportunity forecast link for future updates, as the agency has not yet determined set-aside status or eligibility requirements for small businesses or other preferred categories.